Home/Filings/4/0001140361-23-010184
4//SEC Filing

Zago Wagner M. 4

Accession 0001140361-23-010184

CIK 0001559053other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:30 PM ET

Size

5.6 KB

Accession

0001140361-23-010184

Insider Transaction Report

Form 4
Period: 2023-03-02
Zago Wagner M.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-02+48,00048,000 total
    Exercise: $52.97Exp: 2033-03-02Ordinary Shares (48,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Documents

1 file

Issuer

PROTHENA CORP PUBLIC LTD CO

CIK 0001559053

Entity typeother

Related Parties

1
  • filerCIK 0001708681

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:30 PM ET
Size
5.6 KB